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Abstract 
 
Transforming Growth Factor-β (TGFβ) signalling is an important regulator of cellular growth 
and differentiation. The principal intracellular mediators of TGFβ signalling are the Smad 
proteins, which upon TGFβ stimulation accumulate in the nucleus and regulate transcription of 
target genes. To investigate the mechanisms of Smad nuclear accumulation, we developed a 
simple mathematical model of canonical Smad signalling. The model was built using both 
published data and our experimentally determined cellular Smad concentrations (isoforms 2, 3, 
and 4). We found in mink lung epithelial cells that Smad2 (8.5-12 × 104 molecules/cell) was 
present in similar amounts to Smad4 (9.3-12 × 104 molecules/cell), while both were in excess of 
Smad3 (1.1-2.0 × 104 molecules/cell). Variation of the model parameters and statistical analysis 
showed that Smad nuclear accumulation is most sensitive to parameters affecting the rates of R-
Smad phosphorylation and dephosphorylation and Smad complex formation/dissociation in the 
nucleus. Deleting Smad4 from the model revealed that rate-limiting phospho-R-Smad 
dephosphorylation could be an important mechanism for Smad nuclear accumulation. 
Furthermore, we observed that binding factors constitutively localised to the nucleus do not 
efficiently mediate Smad nuclear accumulation if dephosphorylation is rapid. We therefore 
conclude that an imbalance in the rates of R-Smad phosphorylation and dephosphorylation is 
likely an important mechanism of Smad nuclear accumulation during TGFβ signalling. 
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1. Introduction 
 
Transforming growth factor-β (TGFβ) signalling controls diverse cellular processes, including 
cell proliferation, differentiation, migration, and apoptosis [1]. TGFβ is a member of the TGFβ 
superfamily of cytokines, which also includes bone morphogenic proteins, Mullerian inhibitory 
substance, activin, inhibin, and Nodal [2]. Defects in TGFβ signalling can lead to a variety of 
diseases, including cancer [3, 4]. Our ability to control TGFβ signalling during disease states 
depends on understanding the mechanisms of TGFβ signalling. 
 
The principal components of TGFβ signalling are the active form of the TGFβ ligand, the 
membrane-bound TGFβ receptors, and the intracellular Smad proteins. The biologically active 
TGFβ ligand is a 25 kDa dimer connected by a disulfide bond formed between two cysteines on 
the monomeric units [5]. Ligand binding to the receptors located at the plasma membrane 
initiates signalling. Most TGFβ-sensitive cells express three distinct receptor proteins, the TGFβ 
type I, II, and III receptors [6]. The type I and type II receptors are serine/threonine kinases that 
transmit the TGFβ signal into the cell primarily via phosphorylation of the Smad proteins [7]. 
The eight predominant Smad isoforms are functionally classified into 3 groups: the receptor-
regulated Smads (R-Smads; isoforms 1, 2, 3, 5, and 8), the common-mediator Smad (Co-Smad; 
isoform 4), and the inhibitory Smads (I-Smads; isoforms 6 and 7) [8]. The R-Smads are 
substrates for the receptors in the TGFβ family [2]. In this paper, we focus on Smad isoforms 2, 
3, and 4 because these isoforms mediate TGFβ signalling [2, 9]. 
 
 Canonical TGFβ signalling begins with exposure of cells to TGFβ ligand, which leads to 
receptor activation. Smad2 and Smad3 (the R-Smads) interact with and are phosphorylated by 
the type I receptor. Upon phosphorylation, the R-Smads form a complex with Smad4. The 
phospho-R-Smad/Smad4 complex translocates into the nucleus, binds to various proteins and 
DNA, and regulates transcription. The principal output of TGFβ signalling appears to be 
transcriptional regulation. 
 
 A distinctive feature of TGFβ signalling is the nuclear accumulation of the Smads. The 
regulation of Smad nuclear accumulation is poorly understood. Two mechanisms have been 
proposed: (i) the nucleocytoplasmic-shuttling-kinetics hypothesis and (ii) the retention-factor 
hypothesis [10]. The nucleocytoplasmic-shuttling-kinetics hypothesis states that the different 
forms of the Smads have different kinetics of nuclear import and export, such that the 
phosphorylated Smads accumulate in the nucleus. The retention-factor hypothesis states that 
binding factors in the cytoplasm have a higher affinity for unphosphorylated Smads whereas 
binding factors in the nucleus have a higher affinity for phosphorylated Smads. Candidate 
retention factors include the protein SARA (Smad anchor for receptor activation) [11, 12] and 
microtubules [13] in the cytoplasm and transcription factors and DNA in the nucleus [see 
reference 8 for a list of Smad-interacting transcription factors]. Since Smad nuclear accumulation 
is required for transcriptional regulation, our understanding of TGFβ signalling mechanisms 
depends on which hypothesis, if either, is correct. 
 
 While both hypotheses are reasonable, neither can completely account for existing data. 
For example, identical time courses of nuclear import for unmodified and phosphorylated Smads 
have been observed [14], which agrees with the more recent result that Smad3 and TGFβ-
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activated phospho-Smad3 are transported by a similar mechanism [15]. This work suggests that 
nucleocytoplasmic shuttling kinetics do not control Smad nuclear accumulation. Similarly, 
published data are not fully consistent with the idea that retention factors determine Smad 
signalling kinetics. First, the Smads cycle between the cytoplasmic and nuclear compartments at 
a significant rate, indicating that they are highly mobile within the cell. Treatment of cells with 
leptomycin-B, which blocks Smad4 nuclear export, induces constitutive nuclear localization of 
Smad4 within 10 min [16]. Second, strong tethering of phospho-R-Smads to nuclear retention 
factors during TGFβ signalling would limit the availability of the phospho-R-Smads for 
dephosphorylation. However, application of a TGFβ-type I receptor inhibitor during TGFβ 
signalling causes noticeable phospho-R-Smad dephosphorylation within minutes [17], indicating 
that the phospho-R-Smads are readily available for dephosphorylation. Third, existing evidence 
suggests that constitutive nucleocytoplasmic shuttling of the Smads allows for receptor activity 
monitoring [18], implying that a pool of Smads is freely mobile. Therefore, the retention-factor 
hypothesis cannot fully account for known Smad dynamics. The shortcomings of both 
hypotheses suggest that other unrecognised mechanisms might be important for determining 
Smad nuclear accumulation. Furthermore, various mechanisms could interact to effect Smad 
nuclear accumulation, making experimental determination difficult. The complexity of even the 
canonical TGFβ signalling pathway warrants a systems approach to this problem. Here we use 
mathematical modelling to understand the control of Smad nuclear accumulation. 
 
 Mathematical modelling has been used to analyse several cellular signalling systems 
including those that respond to EGF [19-21], PDGF [22], insulin [23], IFN-γ [24, 25], Wnt [26], 
and TNF-α [27]. Intracellular events in TGFβ signalling have not yet been modelled, although 
recent work has addressed signal processing at the receptor level [28]. Modelling serves to 
efficiently develop and/or assess competing hypotheses about complex signalling networks [e.g., 
above references, 29, 30, 31]. Modelling has also highlighted principles such as robustness [32, 
33] and bistability [34, 35], and has been essential for the design of artificial signalling systems 
[36, 37]. While many cellular signalling systems have been modelled in isolation, the 
phenomenon of crosstalk will to lead to integrated models of multiple pathways. Such 
developments would be useful to the TGFβ field given that the effects of TGFβ are pluripotent 
and context-dependent, which may result from the multiple interactions of the Smads with other 
pathways [38-41]. Our model of TGFβ signalling is a useful first step in the development of an 
integrated multi-pathway model that includes the TGFβ pathway. 
 
 In this paper, we develop and analyse a dynamical model of Smad signalling. We sought 
to develop the simplest functional model that could reproduce the major features of Smad 
signalling. The model was based on data from the literature and our laboratory. We studied the 
effects of altering the model parameters on features of the model solutions. We conclude that the 
imbalance between R-Smad phosphorylation and dephosphorylation rates is likely an important 
determinant of Smad nuclear accumulation.  
 
2. Materials and Methods 
 
2.1 Mathematical modelling 
Full justification for the model structure (Figure 1A), rate equations (Figure 1B), initial 
conditions (Table 1), and model input function (Supplementary Figure S1) is provided in the 
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Supplementary Information. The model is a system of nonlinear ordinary differential equations 
based on conservation of mass [42]. The concentration of a species in the model is determined by 
the biochemical reactions in which it participates: 
outin rateratedt
speciesd −=][ . 
 
 For example, R-Smad-Pcyt is produced by the phosphorylation of R-Smadcyt (reaction 1, 
Figure 1) and by the dissociation of the R-Smad-P/Smad4cyt complex (reaction 2, Figure 1) and 
is consumed by binding to Smad4cyt (reaction 2, Figure 1). The rates of reactions 1 and 2 are 
listed in Figure 1B. The mass balance for R-Smad-Pcyt is therefore 
. 
The system of ordinary differential equations was integrated numerically using the 
ode23s solver of Matlab (The MathWorks, Inc.). Statistical analysis was performed in Excel 
(Microsoft) and Matlab. The parameter sets and supporting raw calculations are provided as an 
Excel spreadsheet file in the Supplementary Information (referred to as the “Simulation 
supplement”). 
 
2.1.1 Parameterisation. None of the parameter values for the reactions included in the model are 
currently available in the literature. However, feasible ranges of the parameter values are known 
(Supplementary Table S1). These parameter ranges bounded distributions used in a 
computational sampling procedure inspired by the work of von Dassow et al. [33]. Specifically, 
we found randomly sampled parameter sets that gave qualitatively correct model solutions. The 
qualitative criteria were derived from the data of Pierreux et al. [16] (Section 2.1.2 includes a 
complete description of the criteria). After several rounds of testing, we obtained sufficient 
parameter sets for analysis (dataset1). Further details of the parameter sampling are provided in 
the Supplementary Information. Note that we constrained k5cn to equal 0.1×k5nc in order to 
facilitate the recovery of the R-Smadcyt initial condition at the end of signalling and hence 
increase the probability of finding successful parameter sets.  
 
2.1.2 Dynamics of Smad signalling and criteria for model success. Caroline Hill’s group has 
published several time courses of Smad dynamics. In their most detailed time course, they 
measured the levels of phospho-Smad2 in the nuclei of HaCaT cells. The initially undetectable 
phospho-Smad2 increased to a maximum at ~45 min and then declined over 8 hours [18]. This 
pattern of phospho-R-Smad accumulation occurs for many cell types [e.g., 16, 18, 43-45], 
although the precise kinetics vary. For example, nuclear accumulation of phospho-R-Smads 
peaks after 15 min of TGFβ stimulation in untransformed mesangial cells [46].  
 
 Phosphorylation dynamics are correlated with the dynamics of downstream events. Both 
Smad complex formation during TGFβ and activin signalling [43, 47] and bulk Smad2 and 
Smad3 nuclear accumulation [18] show similar kinetics to those of Smad phosphorylation. Smad 
[ ] [ ][ ]( ) [ ] [ ] [ ]cytcytacytdcyt cytcat
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nuclear accumulation and exit is matched by Smad cytoplasmic exit and accumulation, 
respectively [16, 18]. Therefore Smad phosphorylation by the active receptor complex leads to 
downstream events such as Smad complex formation and nuclear accumulation. To constrain the 
model dynamics, we used the data of Pierreux et al. [16] to develop criteria for model success. 
Prior to listing the criteria, we define variables that correspond to those observed in the 
experimental data. Pierreux et al. [16] performed immunoblots of cytoplasmic and nuclear 
fractions using anti-Smad2 and anti-Smad4 antibodies. These antibodies recognize all forms of 
their target Smad molecules. Therefore, we defined the four variables: (1) ∑RSmadcyt (sum of R-
Smadcyt, R-Smad-Pcyt, and R-Smad-P/Smad4cyt), (2) ∑RSmadnucl (sum of R-Smadnucl, R-Smad-
Pnucl, and R-Smad-P/Smad4nucl), (3) ∑Smad4cyt (sum of Smad4cyt and R-Smad-P/Smad4cyt), and 
(4) ∑Smad4nucl (sum of Smad4nucl and R-Smad-P/Smad4nucl). The model outputs must satisfy 
five criteria: (1) The minimum of ∑RSmadcyt must occur between 15 and 180 min, with the value 
at the final time point (480 min) greater than the average of the maximum and minimum values. 
This forces the cytoplasmic R-Smad concentration to decrease to a minimum and then recover by 
the end of signalling. (2) The maximum of ∑RSmadnucl must occur between 15 and 180 min, 
with the value at the final time point less than 50% of the maximum value. (3) The minimum of 
∑Smad4cyt must occur between 15 and 180 min, with the value at the final time point greater 
than the average of the maximum and minimum values. (4) The maximum of ∑Smad4nucl must 
occur between 15 and 180 min, with the level at the final time point less than 50% of the 
maximum value. (5) No negative or poorly scaled values are permitted: we require that the 
maximum number of molecules for any of the model state variables cannot be less than 10. We 
chose broad ranges of times for when the maxima or minima could occur because, as discussed 
above, these time ranges vary between cell types. In addition, this choice allowed us to capture a 
sufficiently large parameter ensemble. 
 
2.2 Experimental Procedures 
 
2.2.1 Immunoblotting. Cell lysates were prepared by growing 10 cm plates of cells to confluence 
in DMEM supplemented with 10% FBS, 100 IU/mL penicillin, 100 µg/mL streptomycin, and 
2mM L-glutamine, followed by trypsinisation, counting, and lysis (Lysis buffer: 50 mM Tris-
HCl, 400 mM NaCl, 1 mM EDTA, 1% NP-40, 15% glycerol, 2 mM sodium fluoride, 1 mM 
sodium orthovanadate, and protease inhibitors (Roche 1 697 498)). Protein concentrations were 
measured using the BCA assay (Pierce 23225). Lysates were separated by SDS-PAGE, 
transferred to a nitrocellulose membrane, and immunoblotted using antibodies against Smad2 
(Zymed 51-1300), phospho-Smad2 (a gift from Dr. Aris Moustakas), Smad3 (Zymed 51-1500), 
Smad4 (B-8, Santa Cruz sc-7966), or α-tubulin (MP Biomedicals 691251). Detection was 
performed using either chemifluorescence (ECL Plus, Amersham RPN 2132) or 
chemiluminescence (Supersignal West Dura Extended Duration Substrate, Pierce 34076). 
Exposures were performed for different lengths of time to ensure that band intensities fell into 
the linear range.  
 
2.2.2 Quantitative immunoblotting. Quantitative immunoblots were performed by comparing the 
band intensities of cell lysates to a standard curve of recombinant protein dilutions. Recombinant 
GST-fused human Smad2, Smad3, and Smad4 were purified from E. coli using standard 
procedures, the expression vectors for which are described in Zhang et al. [48]. The 
concentrations of the purified proteins were determined by separating the proteins alongside a 
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series of BSA dilutions of known concentration (Pierce), followed by Coomassie staining and 
densitometry. The recombinant proteins were serially diluted and separated alongside the cell 
lysates by SDS-PAGE followed by immunoblotting as described above. The diluted recombinant 
protein was use to generate a standard curve and the cellular protein content was interpolated 
from those curves. Raw data and calculations for the quantitative immunoblotting experiment are 
provided in spreadsheet form as Supplementary Figure S2, with the live spreadsheet posted 
online (“Smad quantification supplement”). 
 
2.2.3 TGFβ time course. Cells were grown to confluence in 10 cm dishes. Five millilitres of 
media supplemented with 50 pM TGFβ was applied to the cells for the indicated times. At the 
end of the time period, cells were rinsed twice with phosphate-buffered saline and frozen with 
liquid nitrogen. Cells were stored at -80oC until lysis. 
 
3. Results 
 
3.1 Smad quantification assays. We estimated the number of cellular Smad proteins by 
quantitative immunoblotting of Mv1Lu cell lysates. Confidence intervals for the cellular 
molecule numbers are provided in Table 2 with raw data and calculations supplied as 
Supplementary Information (Figure S2, Smad quantification supplement). We observed that 
Smad2 and Smad4 were present in similar amounts, while Smad3 was present in amounts 4- to 
5-times less than Smads 2 and 4. This finding was consistent across several cell lines 
(Supplementary Figure S3, Table S2). These results were used to establish the model initial 
conditions (Table 1). To account for the larger abundance of Smads in several TGFβ-sensitive 
cell lines (Supplementary Figure S3, Table S2, reference [49]), the initial conditions were set to 
higher total numbers of Smads than our estimates. We note that the model behaviour is robust to 
changes in the initial conditions (data not shown). 
 
3.2 The model qualitatively reproduces Smad signalling dynamics. We determined sets of 
parameter values that led to qualitatively correct model outputs. We randomly sampled 
parameters sets and found 203 sets that led to solutions satisfying all 5 criteria (successful 
parameter sets are listed in the Simulation supplement). Supplementary Figure S4 shows the 203 
curves associated with the first four criteria, demonstrating that the model faithfully reproduces 
the qualitative trends from the published data [16] over a range of biologically plausible 
parameter values. We show a representative result in Figure 2A in which the model was run 
using the median parameter values (Table 3). To provide further evidence that our model outputs 
were qualitatively correct, we performed a time course of Smad2 phosphorylation in mink lung 
epithelial cells in response to TGFβ stimulation. Figure 2B shows a representative plot of ΣR-
Smad-P (the sum of all phospho-R-Smad species in the cell) versus time with the experimental 
data shown below. The model captures the trends in the data. Also, the Smad4 blot validates our 
assumption of constant Smad4 concentration during signalling. 
 
3.3 Parameter sensitivity and correlations. We used our set of successful parameters to study the 
sensitivity of the model behaviour to the parameter values. We first examined the ranges of each 
parameter in dataset1. If a parameter must fall within a relatively narrow range for the model to 
be successful, the model is more sensitive to changes in the value of that parameter. As shown in 
Table 3 (rightmost column), most of the parameter values varied by more than 4 orders of 
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magnitude. The two exceptions were kcat1, the turnover number of the receptor kinase, which was 
distributed over only 2.84 orders of magnitude, and k6d, the dissociation rate constant for the 
nuclear Smad complex, which was distributed over 3.04 orders of magnitude. The qualitative 
performance of the model is therefore most sensitive to kcat1 and k6d. 
 
 Proper model behaviour may depend on ratios of parameters. To examine this possibility, 
we calculated pairwise correlations for all the parameters. Two pairs of parameters were highly 
significantly correlated (P<10-16): (1) kcat1 and K1 and (2) k6a and k6d (the full correlation matrix 
is provided in Supplementary Table S3). The median ratio for kcat1/K1 was 1.30×10-5 
cell·molecule-1·min-1 and for k6d/k6a was 508 molecules·cell-1. Appropriate model behaviour 
requires that the parameters determining the rates of Smad phosphorylation and nuclear 
reversible complex formation be constrained to those ratios.  
 
The receptor catalytic efficiency, kcat1/K1, is within range of known values for enzymes 
[50] (see the Simulation supplement for calculations). The ratio k6d/k6a is equivalent to the 
dissociation constant (Kd) of phospho-R-Smad and Smad4. The published estimate for the Kd of 
active Smad2 and Smad4 is 79 nM [51]. Assuming a nuclear volume of 10-13 L [52], conversion 
of 508 molecules·cell-1 to units of mol·L-1 gives ~8 nM, which compares reasonably well with 
the published estimate. Similarly, the median ratio for k2d/k2a, which corresponds to the same 
reaction as k6d/k6a except in the cytoplasm (reaction 2), was ~1 nM. We emphasize that no a 
priori constraints were placed on any of k2a, k2d, k6a, and k6d during the parameter search 
procedure. This result implies that the parameter search procedure obtained realistic parameter 
values.  
 
Together, the descriptive statistics suggest that the qualitative behaviour of the model was 
affected mainly by kcat1 and k6d. 
 
3.4 Regression analysis of parameter effects. To quantitatively predict how each parameter 
contributes to Smad nuclear accumulation, we employed multiple regression analysis. We 
generated a second dataset, dataset2, which consisted of the predictor and response variables. 
The predictor variables were the model parameters. Parameter values were sampled orthogonally 
by selecting 2 values per parameter, the 25th and 75th quartile values (Table 3), and using those 
values to generate parameter sets containing every combination of the two values for each 
parameter. Because k5cn was constrained to equal 0.1×k5nc, it was not included in the analysis. 
Dataset2 therefore included 212 = 4096 parameter sets (Simulation supplement). An orthogonal 
design is one in which the dot product of any two columns in the design matrix sum to 0 (here 
the factor levels would be assigned -1 or +1). Orthogonal designs imply that the effects of each 
term in the regression model are decoupled, thus allowing for unbiased analysis in which the 
estimators of the regression coefficients are uncorrelated [53]. Two response variables were 
analysed: the time integrals of ∑RSmadnucl (denoted ∫∑RSnucl) and ∑Smad4nucl (∫∑S4nucl). The 
integral is the area under the time-course curve and corresponds to the total number of Smads 
that pass through the nucleus during signalling. This quantity is considered a key determinant of 
TGFβ signalling output [10, 54], so our response variables are biologically relevant. To 
determine the response variables, we ran the model with the new parameter sets and calculated 
the time integrals numerically using the trapezoidal rule. Most model outputs were qualitatively 
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consistent with experimental time course data, but not all met our criteria for model success (see 
Supplementary Figure S5 for the time curves associated with dataset2). 
 
The regression model terms included all main effects (each of the parameters alone) and 
pairwise (the products of all possible parameters pairs) and three-way (the products of all 
possible combinations of three parameters) interaction effects. Higher-order interaction effects 
were used as the error estimate [53]. Complete results and residual diagnostic plots for the full 
regression model are included in the Simulation supplement. We observed that the main effect 
and binary and ternary interaction terms account for almost all of the response variable variance: 
the adjusted R2 values for the full regression models were 98.48% for ∫∑RSnucl and 98.46% for 
∫∑S4nucl (Table 4). This result implies that our orthogonal sampling strategy was effective. 
 
To determine the model parameter sensitivities, we compared the predictive ability of 
different regression models (quantified by the adjusted R2 value) in which each of the predictor 
variables was eliminated one-at-a-time from the full regression model. The more important a 
predictor variable is, the more the adjusted R2 decreases upon removal of the variable from the 
full regression model. The removal of either of the two parameters associated with R-Smad 
phosphorylation, kcat1 and K1, caused the greatest decrease in the adjusted R2 for both ∫∑RSnucl 
and ∫∑S4nucl (Table 4). Removal of k6d also had substantial impact on the adjusted R2 values for 
both ∫∑RSnucl and ∫∑S4nucl. The parameters vmax7 and K7 were important determinants of the 
adjusted R2 value for ∫∑RSnucl, while k4nc and k6a were important determinants of the adjusted R2 
value for ∫∑S4nucl. The removal of k2a, k2d, k3, k4cn, or k5nc had either no effect or even a positive 
effect on the adjusted R2 for both ∫∑RSnucl and ∫∑S4nucl.  Together, these results suggest that the 
rate of R-Smad phosphorylation is the most important determinant of overall Smad nuclear 
accumulation. To a lesser extent, parameters involved in reversible Smad complex formation in 
the nucleus (k6a, k6d), R-Smad dephosphorylation (vmax7, K7), and Smad4 availability in the 
nucleus (k4nc) are also important determinants of Smad nuclear accumulation. To further explore 
the roles of these parameters in Smad dynamics, we examined the reaction rates.  
 
3.5 Analysis of rates. The rate of change in concentration of a species is determined by the rates 
of the reactions in which it is involved. We calculated the reaction rates by substituting the 
concentrations of the species at each time point into the rate equations (Figure 1B). Figure 3A 
shows the absolute values of the reaction rates for the median parameter set. We note that only 2 
curves are labelled, because all the rates tend to approach either curve 1 (reactions 1, 2, and 3) or 
curve 2 (reaction 4, 5, 6, and 7). Reactions 1, 2, and 3 represent R-Smad phosphorylation, 
reversible Smad complex formation in the cytoplasm, and Smad complex nuclear import, 
respectively. Reactions 4, 5, 6, and 7 represent Smad4 nuclear shuttling, R-Smad nuclear 
shuttling, reversible Smad complex formation in the nucleus, and phospho-R-Smad 
dephosphorylation. Curves 1 and 2 intersect at the time roughly corresponding to maximal Smad 
nuclear accumulation (Figure 3B), with the magnitudes of the rates associated with curve 1 
initially higher than those of curve 2. This suggests that the time at which the rates intersect – 
that is, the time when the rate of R-Smad dephosphorylation first becomes larger than the rate of 
R-Smad phosphorylation – may predict the time of maximal Smad nuclear accumulation. To test 
this possibility, we calculated the time at which the rate of dephosphorylation (reaction 7) was 
equal to that of R-Smad phosphorylation (reaction 1) and the time of maximal nuclear ΣR-Smad 
concentration using the parameters in dataset1. Similarly, we calculated the time at which the 
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rate of Smad complex formation (reaction 6) intersected that of R-Smad phosphorylation and the 
time of maximal nuclear ΣSmad4 concentration (raw numbers are provided in the Simulation 
supplement). In both cases, the times were correlated (Figures 3C and 3D).  
 
It appears that the rate of phosphorylation sets the overall rate of cytoplasmic events. 
Initially, this rate is higher than the rates of nuclear reactions, which promotes Smad nuclear 
accumulation. The decrease of receptor activity reduces the rates of the cytoplasmic reactions 
while the increase in Smad concentration in the nucleus increases the rates of the nuclear 
reactions. This continues until the rates of the nuclear reactions overtake those of the cytoplasm. 
The Smads then relocalise to the cytoplasm. However, we have not yet addressed which of the 
nuclear reactions is principally responsible for setting the rates of the other nuclear reactions. 
 
3.6 Dephosphorylation could be the rate-limiting reaction in the nucleus. Our results suggest that 
the reactions principally controlling Smad nuclear accumulation are (i) the phosphorylation of 
the cytoplasmic R-Smads by active receptors, (ii) reversible Smad complex formation in the 
nucleus and, (iii) the dephosphorylation of phospho-R-Smads in the nucleus. To further evaluate 
the roles of reversible Smad complex formation and R-Smad dephosphorylation as controlling 
steps in Smad signalling, we studied the model without Smad4. Smad4 is often inactivated in 
colon cancer and pancreatic cancer cell lines [4]. However, the kinetics of R-Smad 
phosphorylation and nuclear translocation are not necessarily affected by the loss of Smad4 [43, 
55]. To see whether the model could replicate R-Smad signalling in Smad4-null cell lines, we 
adjusted the initial condition of Smad4. For all results shown in Figures 4 and 5, the model was 
altered to include reaction 8, which describes the nuclear import reaction for R-Smad-Pcyt (Figure 
1). We used the median parameter set (Table 3) and set the rate constant of phospho-R-Smad 
nuclear import (k8) equal to the median rate constant of nuclear import for the phospho-R-
Smad/Smad4 complex (k3=16.6 min-1). Figure 4A shows the effect of reducing the cellular 
Smad4 concentration on the simulated time course of ∑R-Smad nuclear accumulation. In 
contrast to published data [43], R-Smad nuclear accumulation is lost with decreasing Smad4. To 
determine if different parameter values for R-Smad phosphorylation and dephosphorylation 
could force the model to replicate the known behaviour of the R-Smads with Smad4 deletion, we 
tested all combinations of 4 different values for each of vmax7, K7, kcat1, and K1 (values are listed 
in Supplementary Table S4 and in the Simulation supplement), with the other parameter values 
set at their median values. The resulting 256 curves show that the model is capable of replicating 
R-Smad kinetics with Smad4 deleted (Figure 4B). The curves highlighted in blue are those that 
satisfy the first, second, and fifth criteria for model success (76/256 curves). We calculated the 
means of the 76 values for each of the four adjusted parameters and used those values as the 
basis for a new parameter set, in which the remaining parameters were set to their median values 
from dataset1 (Table 5). Running the model with the new parameter set revealed less decrease of 
nuclear R-Smad accumulation under conditions of decreasing Smad4 (Figure 4C). Therefore, 
slow dephosphorylation can preserve R-Smad nuclear accumulation independent of Smad4 
concentration. We conclude that phospho-R-Smad dephosphorylation in the nucleus could be a 
viable mechanism for Smad nuclear accumulation. 
 
3.7 Is slow phospho-R-Smad dephosphorylation required for Smad nuclear accumulation? Rate-
limiting phospho-R-Smad dephosphorylation is sufficient for Smad nuclear accumulation in our 
model; we asked whether rate-limiting dephosphorylation is also necessary for Smad nuclear 
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accumulation. To estimate the contribution of phospho-R-Smad dephosphorylation to Smad 
nuclear accumulation, we examined the limiting behaviour of very rapid phospho-R-Smad 
dephosphorylation. This allowed us to test whether R-Smad nuclear accumulation can occur 
solely by reversible complex formation with binding factors, represented in our model by 
Smad4. 
 
The parameter sets and Smad4 initial conditions associated with Figure 4D are listed in 
Table 5. The baseline parameter set includes the new values for the phosphorylation and 
dephosphorylation parameters found in the analysis of Figure 4B. We also adjusted the values of 
k2a, k2d, k6a, and k6d so that the phospho-R-Smad/Smad4 complex Kd = 79 nM [51] in both the 
cytoplasm and nucleus. In addition, we adjusted k4cn = 0.2×k4nc to reflect the Smad4 distribution 
under basal conditions. Figure 4D, curve 1 shows the simulated time course of ∑R-Smadnucl 
using the baseline parameter set.  
 
Our first test examined R-Smad nuclear accumulation under conditions of constant rapid 
nuclear phospho-R-Smad dephosphorylation. We set vmax7 = 106 molecules·cell-1·min-1 and K7 = 
1 molecule·cell-1, with the other parameters unchanged from baseline (Table 5). This change 
eliminates R-Smad nuclear accumulation (Figure 4D, curve 2). Therefore, Smad4 cannot solely 
mediate Smad nuclear accumulation when dephosphorylation is rapid because its affinity for the 
R-Smads is too low. Next, we determined whether adjusting the affinity of the Smad complex 
could restore R-Smad nuclear accumulation. Changing k2a/k2d and k6a/k6d to give an equilibrium 
constant of 1 pM, which is well below the estimated Kd of 79 nM [51], led to substantial R-Smad 
nuclear accumulation but still less than with slow dephosphorylation (Figure 4D, curve 3). 
Therefore, reversible interactions of the Smads with each other could in principle account for 
Smad nuclear accumulation. However, the unphysically high affinity required between the 
Smads confirms that Smad4 is unlikely to act as the sole factor that protects the R-Smads from 
the nuclear phosphatase. 
 
Constitutive nuclear shuttling causes a significant proportion of Smad4 to localise to the 
cytoplasm, even during signalling. We therefore asked whether confining Smad4 to the nucleus 
would enhance its binding to the phospho-R-Smads and increase Smad nuclear accumulation. To 
carry out this test, we sequestered all of the Smad4 molecules in the nucleus by setting k4cn = 104 
min-1 and k4nc = 0, and set the initial condition of Smad4cyt = 0 and that of Smad4nucl = 1.5 × 105 
molecules (Table 5). The remaining parameters were the same as those used to produce curve 3, 
including the Smad complex Kd of 1 pM. To our surprise, we found that under conditions of 
rapid dephosphorylation, R-Smad nuclear accumulation decreased when Smad4 was localised to 
the nucleus (Figure 4, curve 4). This result is more dramatic when the affinity of the binding 
factor is further reduced. We set k2a/k2d and k6a/k6d to 1 nM, which still represents a higher 
affinity than that experimentally observed for active R-Smad and Smad4. We ran the model with 
Smad4 normally localised and with Smad4 confined to the nucleus. If the binding factor is 
localized to the cytoplasm, then R-Smad nuclear accumulation occurs, although less so than 
when the affinity is 1 pM (Figure 4D, curve 5). If the binding factor is localised to the nucleus, 
no R-Smad nuclear accumulation occurs (Figure 4D, curve 6). 
 
 Given the reduced ability of constitutively nuclear Smad4 to promote Smad nuclear 
accumulation, we examined what the concentration requirement would be for retention factors 
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that bind the R-Smads with lower affinity. One possible retention factor is DNA, which is 
thought to be a candidate for Smad tethering [10, 56]. The affinity of the Smad3 MH1 domain, 
which contains the Smad DNA binding motif, for a sequence of DNA containing the putative 
Smad binding element (SBE, 5’-GTCT-3’) is approximately 100 nM [57]. We used nuclear-
localised Smad4 to represent the DNA binding sites and set the Kd of phospho-R-Smad and 
Smad4 to 100 nM (Table 5). We then solved the model with increasing amounts of Smad4 and 
plotted the corresponding ΣR-Smadnucl. When dephosphorylation is rapid, detectable amounts of 
R-Smad nuclear accumulation above the basal nuclear amount (Figure 5, curve 1) required ~15 × 
108 binding sites (Figure 5, curve 2). Achieving maximal nuclear accumulation corresponding to 
slightly less than 50% of the total R-Smads (>8 × 104) in the nucleus required ~63 × 109 nuclear 
binding sites (Figure 5, curve 4). Since only 6 × 109 base pairs constitute the entire human 
genome [58, p. 222], DNA is unlikely to be the sole mediator of Smad nuclear retention. Finally, 
we repeated the analysis except we let the nuclear factors bind phospho-R-Smad with Kd = 1 pM. 
Even with such tight binding, ~7.5 × 105 binding sites would be required to achieve ~8 × 104 R-
Smads maximally accumulated in the nucleus during signalling (Supplementary Figure S6). 
Therefore, if a retention factor is responsible for Smad nuclear accumulation when 
dephosphorylation is rapid, the factor must have both high affinity and high abundance. We 
conclude that rate-limiting phospho-R-Smad dephosphorylation is at least partially responsible 
for Smad nuclear accumulation. 
 
4. Discussion 
 
 An important feature of TGFβ signalling is the nuclear accumulation of the Smad 
proteins, which leads to transcriptional regulation of TGFβ-target genes. However, the 
mechanism by which the Smads accumulate in the nucleus is not well understood. Two 
hypotheses exist: the nucleocytoplasmic-shuttling-kinetics hypothesis and the retention-factor 
hypothesis [10]. However, neither hypothesis can fully account for published data. We used 
mathematical modelling to examine the existing hypotheses and to explore alternatives. We 
conclude that the imbalance in the rates of R-Smad phosphorylation in the cytoplasm and 
dephosphorylation in the nucleus likely significantly contributes to Smad nuclear accumulation.  
 
An initial obstacle to our modelling approach was that the kinetic rate constants have not 
previously been measured. We addressed this problem by sampling parameters over a broad 
range of biologically plausible values. Rather than determining one best-fit parameter set, we 
analysed the statistics of many parameter sets that produce qualitatively correct model behaviour. 
Related work studying ensembles of parameters has been done in models of other biochemical 
signalling networks [24, 33, 59-63]. Further development and refinement of these methods is 
necessary as biological models expand in scope. 
 
 Our parameter sensitivity analysis revealed that changes in the parameters involved in R-
Smad phosphorylation and dephosphorylation and in reversible Smad complex formation in the 
nucleus most affected the degree of Smad nuclear accumulation. In contrast, we observed in the 
regression analysis that k3, k4cn, and k5nc, all nuclear shuttling parameters, were relatively 
unimportant in determining Smad nuclear accumulation. Our results are corroborated by recent 
data showing that different nuclear import/export rates cannot explain TGFβ-mediated Smad 
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nuclear accumulation [64]. Hence, the nucleocytoplasmic-shuttling-kinetics hypothesis likely 
does not account for Smad nuclear accumulation.  
 
 Further insight into the dynamics of Smad signalling resulted from the analysis of 
reaction rates. We found that the rates of cytoplasmic reactions tend to approach the same rate, as 
do the rates of nuclear reactions. During signalling, the rates of the cytoplasmic reactions are 
initially high but decrease as receptor activity decreases, eventually becoming less than the rates 
of the nuclear reactions. The time when the cytoplasmic and nuclear reaction rates are equal 
predicts the time of maximal Smad nuclear accumulation. Because R-Smad phosphorylation is 
the first intracellular step in signalling and because the rate constants associated with this 
reaction, kcat1 and K1, are sensitive parameters, we propose that the rate of R-Smad 
phosphorylation sets the overall rate of signalling.  
 
We then sought to identify which nuclear reaction was rate-limiting. Since the parameters 
involved in two nuclear reactions (Smad complex formation and R-Smad dephosphorylation) 
were identified as important, either a slow phosphatase or Smad4-mediated sequestration of the 
R-Smads from dephosphorylation could control Smad nuclear accumulation. To distinguish 
these possibilities, we studied the effects of changing the parameter values and Smad4 
abundance and/or localisation. Either a slow phosphatase or Smad4-mediated sequestration alone 
could in principle mediate Smad nuclear accumulation. Specifically, when Smad4 is deleted, 
slow dephosphorylation can lead to Smad nuclear accumulation. Similarly, if dephosphorylation 
is rapid, then changing the binding affinity of the phospho-R-Smad/Smad4 complex can also 
lead to R-Smad nuclear accumulation. In the latter case, however, we observed that the required 
Kd for the Smad complex was ~1 pM, which is considerably less than the reported estimate of 79 
nM [51]. This suggests that the affinity between phospho-R-Smad and Smad4 is not sufficiently 
high to permit Smad4 to protect the phospho-R-Smads from rapid dephosphorylation in the 
nucleus. This result supports the notion that dephosphorylation is at least partially responsible for 
Smad nuclear accumulation. 
 
 To confirm that dephosphorylation must be at least partially rate-limiting, we tested the 
effects of binding factors localised exclusively in the nucleus. (When the binding factors are 
nuclearly localised, we alter the model to allow Smad4-independent nuclear import of phospho-
R-Smad). We expected that restricting the binding factors to the nucleus would enhance Smad 
nuclear accumulation and therefore make dephosphorylation less important. Instead, nuclear-
localised binding factors decrease R-Smad nuclear accumulation when dephosphorylation is 
rapid. In this case, the phosphatase rapidly dephosphorylates the imported unbound phospho-R-
Smad before it can interact with a binding factor. This result implies that if nuclear retention 
factors are the principal mechanism for Smad nuclear accumulation, then such factors should 
either be present at high abundance or they should bind the phospho-R-Smads with high affinity. 
Therefore nuclear retention factors are unlikely to be the sole mechanism of Smad nuclear 
accumulation. Instead, we propose that an imbalance in the rates of R-Smad phosphorylation and 
dephosphorylation must significantly contribute to Smad nuclear accumulation. 
 
 At present, our model cannot address one alternative scenario that could support the 
retention-factor hypothesis: oligomerisation of the Smads into multimeric complexes could be 
important. We made the simplifying assumption that the phospho-R-Smads form heterodimeric 
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complexes with Smad4. Our assumption is justified from experimental evidence showing that R-
Smads and Smad4 form heterodimers [51, 65, 66]. However, we ignore the possible effects of 
phospho-R-Smad homodimers and phospho-R-Smad/Smad4 heterotrimers, which have been 
shown to occur in structural studies in vitro and upon overexpression in vivo [67, 68]. In future 
theoretical work we plan to address whether participation of the Smads in larger complexes can 
better sequester the phospho-R-Smads from dephosphorylation. This issue is particularly 
relevant given our finding that complexes formed in the cytoplasm more effectively sequester the 
phospho-R-Smads from rapid dephosphorylation than factors localised exclusively in the 
nucleus. In this way, the Smads could act as their own nuclear retention factors.  
 
In addition, a similar phenomenon could occur in the nucleus given the number of 
transcription factors known to interact with the Smads [8]. Formation of multiple types of 
complexes in the nucleus could also significantly modulate the kinetics of Smad nuclear 
accumulation. Indeed, indirect evidence of these complexes occurring in vivo exists as the 
mobility of overexpressed fluorescent-protein-tagged Smad2 in the nucleus is substantially 
decreased upon TGFβ signalling [56, 64]. The reduction in mobility was interpreted as regulated 
tethering of the Smads in the nucleus, suggesting that nuclear retention is the mechanism of 
Smad nuclear accumulation [64]. However, other work suggests that transcriptional activation 
complexes are highly dynamic: components are continually binding to and dissociating from the 
complex [69]. If participation of individual Smad molecules in large complexes is transient, then 
such complexes are unlikely to sequester the phospho-R-Smads from rapid dephosphorylation. 
Moreover, participation of the Smads in complexes is not mutually exclusive with the hypothesis 
that the principal mechanism of Smad nuclear accumulation is an imbalance in R-Smad 
phosphorylation and dephosphorylation rates. Smad nuclear accumulation mediated by slow 
dephosphorylation could drive reversible interactions involving the Smads in the direction of 
complex formation, thus promoting the ability of the Smads to regulate transcription. At this 
time, little data is available on the copy numbers and affinities for the Smads of transcription 
factors and other putative nuclear binding partners. Therefore, we are currently unable to specify 
how much retention factors versus an imbalance in phosphorylation/dephosphorylation rates 
contribute to Smad nuclear accumulation. We do conclude, however, that both mechanisms are 
likely to significantly contribute to Smad nuclear accumulation. 
 
We integrate our observations to propose the following sequence for TGFβ signalling: 
Ligand binding rapidly activates the receptor kinases and the rate of Smad phosphorylation 
quickly increases and surpasses the rate of dephosphorylation. The Smads form complexes in the 
cytoplasm that are imported into the nucleus. The Smad complexes accumulate in the nucleus 
because the phosphatase cannot dephosphorylate the phospho-R-Smads rapidly enough to 
prevent accumulation. This is due to an intrinsically slow phosphatase but also to sequestration 
of the phospho-R-Smad from the phosphatase by participation in complexes. However, as 
receptors are downregulated, the rate of phosphorylation eventually decreases below that of 
dephosphorylation. At this time, the accumulation of Smads in the nucleus begins to subside and 
returns to basal levels.  
 
Our model leads to important suggestions for the control of Smad dynamics and for the 
design of therapies for diseases involving TGFβ signalling. The cell has various means to 
regulate Smad signalling: the expression levels of the receptors, the nuclear phosphatase, and 
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binding partners in the cytoplasm and nucleus could be balanced to ensure proper Smad 
signalling kinetics. (Note that not all cells necessarily adjust these expression levels to maintain 
Smad dynamics, as Smad nuclear accumulation in certain cancer cell lines expressing low levels 
of TGFβ receptors is of shorter duration [43]). Nonetheless, artificial targeting of phosphatase 
expression and/or activity could represent a novel potential target for therapy in diseases 
involving Smad signalling. Our model predictions therefore stress the need to identify the 
nuclear phosphatase. In addition, our results suggest that if dephosphorylation is rapid, then 
expressing a binding factor that forms a complex with phospho-R-Smad in the cytoplasm may 
serve as a better nuclear retention factor than the same factor constitutively localised in the 
nucleus. 
 
In summary, we have constructed and analysed a mathematical model of Smad 
signalling. Our findings lead us to conclude that the imbalance between R-Smad phosphorylation 
and dephosphorylation rates is likely a significant mechanism of Smad nuclear accumulation 
during TGFβ signalling. We are currently investigating this hypothesis experimentally.  
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Figure Legends 
Figure 1. (A) Schematic of our Smad signalling model. Reactions are numbered arbitrarily. 
Reaction 8 was included only for model variants used in Figures 4 and 5 to account for Smad4-
independent phospho-R-Smad nuclear import. (B) Model equations. Equations for cytoplasmic 
and nuclear phospho-R-Smad were modified as shown (lower right) when reaction 8 was 
included in the model. 
Figure 2. Representative model solution. (A) Model solution generated using the median 
parameter values. The curves represent the number of molecules per cell of (1) ∑R-Smadnucl, (2) 
∑Smad4nucl, (3) ∑R-Smadcyt, and (4) ∑Smad4cyt. (B) Model simulations compare well with 
experimental data. The plot shows the simulated time course for ∑R-Smad-P (cellular phospho-
R-Smad) generated using the median parameter set. The immunoblot below shows the relative 
levels of phospho-R-Smad in mink lung epithelial cells stimulated with 50 pM TGFβ. The trends 
in the data compare well with the simulation. In the experiment, the membrane was probed for 
Smad4, to verify that the levels of Smad4 are constant for the duration of signalling, and for α-
tubulin, a loading control. 
Figure 3. Reaction rates. (A) Reaction rates generated with the median parameter set. The curves 
show the rates of (1) reactions 1, 2, and 3 and (2) reactions 4, 5, 6, and 7. (B) The time of 
intersection of (1) phosphorylation and (2) dephosphorylation rates is correlated with the time of 
maximal accumulation of the nuclear R-Smads (3), for the solution generated with the median 
parameter set. (C) and (D) The intersection time of reaction rates 1 and 7 correlates with the time 
of maximal R-Smad nuclear accumulation (C) while the intersection time of reaction rates 1 and 
6 correlates with the time of maximal Smad4 nuclear accumulation (D). The model parameters 
from dataset 1 were used to calculate the times at which the rates intersected and the times of 
maximal Smad nuclear accumulation. 
Figure 4. Slow dephosphorylation can mediate Smad nuclear accumulation. (A) The effect of 
reductions in Smad4 concentration on R-Smad nuclear accumulation. Curves of ∑R-Smad were 
generated using the median parameter set (Table 3) and total Smad4 cellular concentrations 
(molecules⋅cell-1) of: (1) 15 × 104, (2) 10 × 104, (3) 5 × 104, and (4) 0. Note that reaction 8, which 
describes the nuclear import of phospho-R-Smad, was included in the model used to generate all 
of the curves in Figure 4. The corresponding parameter, k8, was set to the median value of k3. (B) 
Effect of varying phosphorylation and dephosphorylation parameters on R-Smad nuclear 
accumulation under conditions of Smad4 deletion. All combinations of 4 levels of kcat1, K1, vmax7, 
and K7 (Table S4) were studied; the remaining parameters were set to their median values and 
the concentration of Smad4 was set to 0. Outputs satisfying criteria 1, 2, and 5 (the R-Smad 
criteria) are coloured blue (76 out of 256 curves). (C) The effect of reducing Smad4 
concentration on R-Smad nuclear accumulation using adjusted parameters for R-Smad 
phosphorylation and dephosphorylation (Table 5). The model was integrated with four levels of 
total cellular Smad4 concentration (molecules⋅cell-1): (1) 15 × 104, (2) 10 × 104, (3) 5 × 104, and 
(4) 0. (D) The effect of the dephosphorylation rate, phospho-R-Smad and Smad4 binding 
affinity, and R-Smad binding factor localisation on R-Smad nuclear accumulation. The different 
curves show ∑R-Smadnucl as a function of time for different variants of the model (for parameter 
values, see Table 5): (1) baseline parameters; (2) rapid dephosphorylation; (3) Kd of phospho-R-
Smad and Smad4 set to 1 pM to compensate for the rapid dephosphorylation; (4) Kd of phospho-
R-Smad and Smad4 set to 1 pM and constitutive nuclear localisation of Smad4; (5) Kd of 
phospho-R-Smad and Smad4 set to 1 nM; (6) Kd of phospho-R-Smad and Smad4 set to 1 nM 
and constitutive nuclear localisation of Smad4.  
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Figure 5. Effect of nuclear binding factor concentration on R-Smad nuclear accumulation. The 
curves correspond to time course simulations of ∑R-Smadnucl in which nuclear binding factor 
concentrations were set to (1) 15 × 106, (2) 15 × 108, (3) 25 × 109, and (4) 63 × 109 
molecules⋅cell-1. The Kd of phospho-R-Smad and Smad4 was set to 100 nM (for parameter 
values, see Table 5). 
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Tables 
 
Table 1. Model state variables and initial conditions. 
 
Table 2. Quantification of absolute Smad cellular concentrations in Mv1Lu cells. 
Smad Isoform Molecules per cella 
  
Smad2 1.27-1.77 × 105 
Smad3 1.86-3.84 × 104 
Smad4 1.34-1.67 × 105 
  
a95% confidence intervals, n=6 independent cell lysates 
 
State Variable Description Initial Condition 
(molecules⋅cell-1) 
   
Receptors Active receptors 1.00 × 104 
R-Smadcyt Cytoplasmic R-Smad 1.62 × 105 
R-Smad-Pcyt Cytoplasmic phospho-R-Smad 0 
Smad4cyt Cytoplasmic Smad4 1.20 × 105 
R-Smad-P·Smad4cyt Cytoplasmic phospho-R-Smad/Smad4 complex 0 
R-Smad-P·Smad4nucl Nuclear phospho-R-Smad/Smad4 complex 0 
R-Smadnucl Nuclear R-Smad 1.80 × 104 
R-Smad-Pnucl Nuclear phospho-R-Smad 0 
Smad4nucl Nuclear Smad4 3.00 × 104 
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Table 3. Model parameter quartile values from parameters in dataset1 (n=203). 
Parameter Units Minimum 25th 
Quartile 
Median 75th 
Quartile 
Maximum Range of log10  
max & min 
values 
        
kcat1 – turnover number, TGF-beta type I 
receptor 
min-1 0.272 1.38 3.51 8.25 1.87×102 2.84 
K1 – Michaelis-Menten constant, TGF-beta 
type I receptor 
molecules⋅cell-1 6.33×102 9.14×104 2.89×105 9.78×105 2.27×107 4.55 
k2a – association rate constant, 
phosphorylated R-Smad & Smad4 in the 
cytoplasm 
cell⋅molecules-1⋅ 
min-1 
7.73×10-7 1.60×10-5 6.50×10-5 2.72×10-4 1.51×10-2 4.29 
k2d – dissociation rate constant, 
phosphorylated R-Smad/Smad4 in cytoplasm 
min-1 2.05×10-5 9.73×10-3 3.99×10-2 1.98×10-1 7.71 5.58 
k3 – nuclear import rate, phosphorylated R-
Smad/Smad4 
min-1 4.75×10-2 3.03 16.6 63.0 1.75×103 4.57 
k4nc – nuclear export rate, Smad4 min-1 8.86×10-3 1.54×10-1 7.83×10-1 3.05 69 3.89 
k4cn – nuclear import rate, Smad4 min-1 1.87×10-5 1.24×10-3 4.97×10-3 1.78×10-2 0.398 4.33 
k5nc – nuclear export rate, R-Smad min-1 3.57×10-2 1.12 5.63 27.0 2.47×103 4.84 
k5cna – nuclear import rate, R-Smad min-1 = 0.1*k5nc = 0.1*k5nc = 0.1*k5nc = 0.1*k5nc = 0.1*k5nc 4.84 
k6a – association rate constant, 
phosphorylated R-Smad & Smad4 in the 
nucleus 
cell⋅molecules-1⋅ 
min-1 
6.21×10-7 2.88×10-5 1.44×10-4 7.43×10-4 1.35×10-2 4.34 
k6d – dissociation rate constant, 
phosphorylated R-Smad/Smad4 in the 
nucleus 
min-1 8.53×10-3 2.77×10-2 4.92×10-2 1.16×10-1 9.27 3.04 
vmax7 – maximal velocity, nuclear 
phosphatase 
molecules⋅ 
cell-1⋅min-1 
5.04×102 4.99×103 1.71×104 6.33×104 6.77×106 4.13 
K7 – Michaelis-Menten constant, nuclear 
phosphatase 
molecules⋅cell-1 5.24 2.46×103 8.95×103 2.85×104 6.34×105 5.08 
        
ak5cn was constrained to 10% of k5nc to ensure recovery of the R-Smad initial conditions towards the end of the signalling period. 
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Table 4. Parameter sensitivities from multiple regression analysis. 
Adjusted R2 values 
(%) 
Regression 
Model 
Response variable: 
∫ΣR-Smadnucl 
Response variable: 
∫ΣSmad4nucl 
   
All terms 
included 
98.48 98.46 
   
Parameter 
Removed: 
  
   
kcat1 60.64 62.75 
K1 61.31 63.58 
k2a 98.39 98.41 
k2d 98.51 98.49 
k3 98.51 98.49 
k4nc 92.74 83.01 
k4cn 98.17 97.44 
k5nc 98.49 98.48 
k6a 91.12 90.38 
k6d 85.96 85.28 
vmax7 87.50 93.40 
K7 92.47 95.18 
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Table 5. Model parameters and Smad4 initial conditions used in the analyses for Figures 4 and 5. 
Parameter Units Figure 4C Figure 4D Curve # Figure 5 
   1b 2 3 4 5 6  
          
kcat1  min-1 3.19 3.19 3.19 3.19 3.19 3.19 3.19 3.19 
K1  molecules⋅cell-1 2.09×105 2.09×105 2.09×105 2.09×105 2.09×105 2.09×105 2.09×105 2.09×105 
k2a  cell⋅ molecules-1 ⋅min-1 6.50×10-5 1.17×10-6 1.17×10-6 9.23×10-2 9.23×10-2 9.23×10-5 9.23×10-5 9.23×10-7 
k2d  min-1 3.99×10-2 0.05 0.05 0.05 0.05 0.05 0.05 0.05 
k3  min-1 16.6 16.6 16.6 16.6 16.6 16.6 16.6 16.6 
k4nc  min-1 0.783 0.783 0.783 0.783 0 0.783 0 0 
k4cn  min-1 4.97×10-3 0.157 0.157 0.157 1×104 0.157 1×104 1×104 
k5nc  min-1 5.63 5.63 5.63 5.63 5.63 5.63 5.63 5.63 
k5cn  min-1 0.563 0.563 0.563 0.563 0.563 0.563 0.563 0.563 
k6a  cell⋅ molecules-1 ⋅min-1 1.44×10-4 1.05×10-5 1.05×10-5 0.831 0.831 8.31×10-4 8.31×10-4 8.31×10-6 
k6d  min-1 4.92×10-2 0.05 0.05 0.05 0.05 0.05 0.05 0.05 
vmax7  molecules⋅cell-1 ⋅min-1 1.18×104 1.18×104 1×106 1×106 1×106 1×106 1×106 1×106 
K7  molecules⋅cell-1 7.29×104 7.29×104 1 1 1 1 1 1 
k8 min-1 16.6 16.6 16.6 16.6 16.6 16.6 16.6 16.6 
          
Kda  
(R-Smad-P/ 
Smad4): 
nM  79 79 1×10-3 1×10-3 1 1 100 
Smad4 
initial 
conditions: 
         
Smad4cyt molecules⋅cell-1 1.2×105 1.2×105 1.2×105 1.2×105 0 1.2×105 0 0 
Smad4nucl molecules⋅cell-1 3×104 3×104 3×104 3×104 1.5×105 3×104 1.5×105 varied 
          
          
          
a Kd = k2d/k2a = k6d/k6a. Conversion from units of molecules⋅cell-1 to nM assumes a volume of 9×10-13 L for the cytoplasm and 1×10-13 L for the 
nucleus. 
b For the baseline parameter set, we constrained k2a, k6a, k2d, and k6d to ensure that the Kd (nM) in the nucleus and cytoplasm was the same. Also, 
we set k4cn = 0.2×k4nc, to reflect the Smad4 partitioning under basal conditions. These constraints were carried through to the other parameter sets 
where appropriate. 
